These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 25934824
41. ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis. Chung HY, Chui ETF, Lee KH, Tsang HHL, Chan SCW, Lau CS. RMD Open; 2019; 5(2):e001008. PubMed ID: 31452930 [Abstract] [Full Text] [Related]
43. Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine. Renson T, Carron P, De Craemer AS, Deroo L, de Hooge M, Krabbe S, Jans L, Chen M, Østergaard M, Van den Bosch FE, Elewaut D. Ann Rheum Dis; 2021 Jan; 80(1):103-108. PubMed ID: 33115761 [Abstract] [Full Text] [Related]
44. Validation of SPARCC MRI-RETIC e-tools for increasing scoring proficiency of MRI sacroiliac joint lesions in axial spondyloarthritis. Maksymowych W, Hadsbjerg AEFEF, Østergaard M, Micheroli R, Pedersen SJ, Ciurea A, Vladimirova N, Nissen MS, Bubova K, Wichuk S, de Hooge M, Mathew AJ, Pintaric K, Gregová M, Snoj Z, Wetterslev M, Gorican K, Möller B, Eshed I, Paschke J, Lambert RG. RMD Open; 2024 Feb 13; 10(1):. PubMed ID: 38351052 [Abstract] [Full Text] [Related]
46. Effects of disease-modifying anti-rheumatic drugs on sacroiliac MRI score in axial spondyloarthritis: a systematic review and meta-analysis. Hansmaennel A, Fakih O, Gerazime A, Prati C, Chouk M, Wendling D, Verhoeven F. Clin Rheumatol; 2024 Mar 13; 43(3):1045-1052. PubMed ID: 38158505 [Abstract] [Full Text] [Related]
51. Candidate lesion-based criteria for defining a positive sacroiliac joint MRI in two cohorts of patients with axial spondyloarthritis. Weber U, Østergaard M, Lambert RG, Pedersen SJ, Chan SM, Zubler V, Rufibach K, Zhao Z, Maksymowych WP. Ann Rheum Dis; 2015 Nov 13; 74(11):1976-82. PubMed ID: 24925836 [Abstract] [Full Text] [Related]
52. Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trial. Mok CC, Li OC, Chan KL, Ho LY, Hui PK. Scand J Rheumatol; 2015 Nov 13; 44(6):480-6. PubMed ID: 26271141 [Abstract] [Full Text] [Related]
56. Impact of tumor necrosis factor α inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis. Huang Y, Chen Y, Liu T, Lin S, Yin G, Xie Q. PLoS One; 2020 Apr 13; 15(12):e0244788. PubMed ID: 33382842 [Abstract] [Full Text] [Related]
57. The diagnostic utility of MRI in spondyloarthritis. Pedersen SJ, Weber U, Ostergaard M. Best Pract Res Clin Rheumatol; 2012 Dec 13; 26(6):751-66. PubMed ID: 23273790 [Abstract] [Full Text] [Related]
59. Magnetic resonance imaging of spondyloarthritis: spine and SI joints. Del Grande F, Carrino JA, Zanetti M. Top Magn Reson Imaging; 2011 Apr 13; 22(2):83-8. PubMed ID: 22648083 [Abstract] [Full Text] [Related]